Abiopharma

GSK plc (GLAXF) Files Form 6-K

(90% Positive) MONTE ROSA THERAPEUTICS, INC. (GLUE) Provides Update on development for today at 8 a

Genprex Provides Clinical Update on Diabetes Gene Therapy Program

10x Genomics - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

(30% Negative) EyePoint, Inc. (EYPT) Announces Delay in Conference Trials for San Francisco on Tuesday Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

(99% Neutral) GENPREX, INC. (GNPX) Files Form 8-K

Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Novo Nordisk International Operations Commits to Veeva Vault CRM

New Form 15-12G - Clearside Biomedical, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005412 Size: 11 KB

KAMADA (KMDA) Files Form 6-K

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Gain Therapeutics Announces Conference Participation During J.P. Morgan Healthcare Conference Week